President Donald Trump is expected to name an ex-Eli Lilly executive as his pick for HHS secretary; Connecticut's new budget will cut Medicaid eligibility; Nebraska lawmaker seeks a Medicaid expansion ballot vote.
Alex Azar, the former president of Lilly USA and deputy secretary of HHS under President George W. Bush, is rumored to be the top choice to run the HHS. Bloomberg reported that President Donald Trump is expected to announce Azar as his pick to lead HHS after Tom Price, MD, resigned from the position at the end of September. Similar to others in Trump’s administration, Azar has advocated for giving states more flexibility under the Affordable Care Act (ACA), and as HHS secretary, he would have authority over many aspects of how the law is implemented.\A recent budget passed in Connecticut will result in about 9500 fewer people being eligible to receive healthcare through Medicaid. Reducing eligibility for the program will save the state approximately $11 million, according to WNPR. Most individuals who are kicked off the plan will still have access to low-cost ACA plans because they have access to federal subsidies. However, the move will also take away state help through a program that subsidizes Medicare Part B premiums for elderly and disabled people.After watching Maine residents vote in favor of expanding Medicaid through a ballot measure, a Nebraska lawmaker wants to give his constituents the same chance. According to The New York Times, a Nebraska state senator will propose a resolution to place the issue on the general election ballot for November 2018. Nebraska lawmakers have already rejected 5 previous attempts to expand Medicaid, but the senator is hoping his colleagues who oppose expansion might be open to letting voters weigh in.
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More